Liquid Biopsy Market (Impact of Covid-19) With Top Players like Biocept, Inc Bio-Rad Laboratories, Inc LungLife AI, Inc Exosome Diagnostics, F. Hoffmann-la Roche ltd, Exact Sciences Corporation Inivata Ltd, MDxHealth, Qiagen, Thermo Fisher Scientific Inc.

An off-the-shelf report on Liquid Biopsy Market which has been compiled after an in-depth analysis of the market trends prevailing across five geographies (North America, Europe, Asia-Pacific, Middle-East and Africa, and South America). Various segments of the market such as type/components/ application/industry verticals/ end-users are analyzed with robust research methodology which includes three step process starting with extensive secondary research to gather data from company profiles, global/regional associations, trade journals, technical white papers, paid databases etc. followed by primary research (interviews) with industry experts/KOLs to gain their insights and views on current scenarios and future scope of the market as well as validating the secondary information, further internal statistical model is used to estimate the market size and forecasts till 2027.

The liquid biopsy market was valued at US$ 3,861.49 million in 2019and is projected to reach US$ 8,123.85 million by 2027; it is expected to grow at a CAGR of 9.9% during 2020–2027.

Get sample PDF copy at: https://www.theinsightpartners.com/sample/TIPRE00003996/?source=openpr-10271

The key players influencing the market are:

Biocept, Inc
Bio-Rad Laboratories Inc
LungLife AI, Inc
Exosome Diagnostics
F. Hoffmann-la Roche ltd
Exact Sciences Corporation
Inivata Ltd
MDxHealth
Qiagen
Thermo Fisher Scientific Inc.

The market players operating in the liquid biopsy market adopt the business expansion to enlarge customer base across the world, collaborations, and product launches. These strategies permit the players to maintain their brand name globally. For instance, in August 2018, Exact Sciences Corp. announced signing of partnership with Pfizer to promote Colorguard in the US. Pfizer has helped with sales representative to promote the test to physicians and health systems during marketing campaign.

Liquid Biopsy Market - By Product & Service

Equipment
Reagents & Kits
Services

Liquid Biopsy Market - By Sample

Blood Based
Urine Based
Other samples

Liquid Biopsy Market - By Circulating Biomarker

Circulating Tumor Cells (CTC)
Exosomes
Free Nucleic Acid

Liquid Biopsy Market - By Application

Noninvasive Prenatal Testing (NIPT)
Oncology
Transplant Diagnostics
Other Applications

Liquid Biopsy Market - By End User

Academic & Research Institutes
Hospitals
Reference Laboratories
Other End Users

Liquid Biopsy Market - By Geography

North America
US
Canada
Mexico
Europe
France
Germany
Italy
UK
Spain
Rest of Europe

Asia Pacific (APAC)
China
India
South Korea
Japan
Australia
Rest of Asia Pacific

Middle East & Africa (MEA)
South Africa
Saudi Arabia
UAE

Rest of Middle East and Africa
South America
Brazil
Argentina
Rest of South America

This report contains:

• Market sizing for the global Liquid Biopsy Market.
• Compare major Liquid Biopsy Market providers strategies and approaches to the challenges they face
• Analysis of the effects deglobalisation trends may have for Liquid Biopsy Market providers
• Profiles of major Liquid Biopsy Market providers
• 7-year CAGR forecasts for Liquid Biopsy Market -intensive vertical sectors

Liquid Biopsy Market- Global Analysis to 2027 is an expert compiled study which provides a holistic view of the market covering current trends and future scope with respect to product/service, the report also covers competitive analysis to understand the presence of key vendors in the companies by analyzing their product/services, key financial facts, details SWOT analysis and key development in last three years. Further chapter such as industry landscape and competitive landscape provides the reader with recent company level insights covering mergers and acquisitions, joint ventures, collaborations, new product developments/strategies taking place across the ecosystem. The chapters also evaluate the key vendors by mapping all the relevant products and services to exhibit the ranking/ position of top 5 key vendors.

Liquid Biopsy Market is a combination of qualitative as well as quantitative analysis which can be broken down into 40% and 60% respectively. Market estimation and forecasts are presented in the report for the overall global market from 2018 – 2027, considering 2018 as the base year and 2018 – 2027 forecast period. Global estimation is further broken down by segments and geographies such as North America, Europe, Asia-Pacific, Middle East & Africa and South America covering major 16 countries across the mentioned regions. The qualitative contents for geographical analysis will cover market trends in each region and country which includes highlights of the key players operating in the respective region/country, PEST analysis of each region which includes political, economic, social and technological factors influencing the growth of the market.

Key Benefits
 This report provides a detailed study of Liquid Biopsy Market trends and forecast from 2020 to 2027, which assist to identify the prevailing market opportunities.
 In-depth coverage of the global Liquid Biopsy market that includes drivers, restraints, and opportunities, helps professionals to understand the market behavior in a better way.
 This study further includes market analysis in terms of type and applications.
 Detailed study of the strategies of key leaders, partnerships, and acquisitions in the Liquid Biopsy Market is provided.

Purchase This Report @ https://www.theinsightpartners.com/buy/TIPRE00003996/?source=openpr-10271

Contact Us:
Call: +1-646-491-9876
Email: sales@theinsightpartners.com

About Us:
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are a specialist in Technology, Semiconductors, Healthcare, Manufacturing, Automotive and Defense.

This release was published on openPR.